Alternative Data for Cronos Group
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 10 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 10,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 20 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 67,088 | Sign up | Sign up | Sign up |
| X Followers | 10,939 | Sign up | Sign up | Sign up |
| X Mentions | 5 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | N/A | Sign up | Sign up | Sign up |
| Lobbying Cost | $N/A | Sign up | Sign up | Sign up |
| Business Outlook | 32 | Sign up | Sign up | Sign up |
| Linkedin Employees | 421 | Sign up | Sign up | Sign up |
About Cronos Group
Cronos Group is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development.
| Price | $2.71 |
| Target Price | Sign up |
| Volume | 1,390,000 |
| Market Cap | $1.06B |
| Year Range | $1.86 - $3.27 |
| Dividend Yield | 0% |
| PE Ratio | 25.27 |
| Analyst Rating | 0% buy |
| Industry | Medical Cannabis |
In the news
Bernstein Reiterates Hold on Cronos Group Inc. (CRON) as Cash-Rich Balance Sheet Stands OutJanuary 25 - Yahoo Entertainment |
|
Cannabis Cultivation Market Analysis Report 2026: $464.91 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FJanuary 27 - GlobeNewswire |
|
Cannabis Beverages Market Size to Exceed USD 7.60 Billion by 2035 | Towards FnBJanuary 21 - GlobeNewswire |
|
Cannabis Cultivation Market - Global Forecast 2025-2032: Transition Towards Organic and Regenerative Cultivation Practices to Meet Consumer Eco DemandsJanuary 13 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 36M | 18M | 18M | 26M | 31M | 0.070 |
| Q2 '25 | 33M | 19M | 15M | -40M | -350,000 | -0.100 |
| Q1 '25 | 32M | 19M | 14M | 6.1M | -680,000 | 0.028 |
| Q4 '24 | 30M | 19M | 11M | 44M | -8.8M | 0.159 |
| Q3 '24 | 34M | 31M | 3.6M | 8.3M | -16M | 0.022 |
Insider Transactions View All
| ADLER JASON MARC filed to buy 1,402,304 shares at $1.7. June 1 '23 |
| ADLER JASON MARC filed to buy 601,016 shares at $1.7. June 1 '23 |
| ADLER JASON MARC filed to buy 1,376,054 shares at $1.8. May 30 '23 |
| ADLER JASON MARC filed to buy 589,766 shares at $1.8. May 30 '23 |
| ADLER JASON MARC filed to buy 1,306,055 shares at $1.9. May 25 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
TilrayTLRY |
$8.42 3.6% | 41 |
 |
Canopy GrowthCGC |
$1.17 1.7% | 29 |
 |
Aurora CannabisACB |
$4.42 2.3% | 30 |
 |
Sundial GrowersSNDL |
$1.6 0.6% | 35 |
 |
OrganigramOGI |
$1.65 3.1% | 35 |
Read more about Cronos Group (CRON) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Cronos Group
The Market Cap of Cronos Group is $1.06B.
As of today, Cronos Group's PE (Price to Earnings) ratio is 25.27.
Currently, the price of one share of Cronos Group stock is $2.71.
The CRON stock price chart above provides a comprehensive visual representation of Cronos Group's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cronos Group shares. Our platform offers an up-to-date CRON stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Cronos Group (CRON) does not offer dividends to its shareholders. Investors interested in Cronos Group should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Cronos Group are Tilray, Canopy Growth, Aurora Cannabis, Sundial Growers, and Organigram.
